z-logo
HomeZAIABlog
open-access-imgOpen Access
Caspofungin und Voriconazol Zwei neue Antimykotika
Author(s) -
Urspeter Masche
Publication year - 2004
Publication title -
pharma-kritik
Language(s) - German
Resource type - Journals
SCImago Journal Rank - 0.101
H-Index - 2
ISSN - 1010-5409
DOI - 10.37667/pk.2004.96
Subject(s) - caspofungin , medicine , gynecology , amphotericin b , antifungal , dermatology
Caspofungin kommt als Reservemittel bei Candida-Infekten in Frage, wenn die gebräuchlichen Mittel versagen. Voriconazol ist bei invasiver Aspergillose mindestens ähnlich wirksam wie Amphotericin B. Beide neuen Antimykotika sind sehr teuer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

AboutCareersPublisher PartnersContact UsGet Organisational Trial or Quote

Learn

FAQsBlogTerms of UsePrivacy Policy

Download the Zendy App

Get it on
Google Play
Download on the
App Store

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.